These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15043685)

  • 1. Redefining the clinical remission period in children with type 1 diabetes.
    Chase HP; MacKenzie TA; Burdick J; Fiallo-Scharer R; Walravens P; Klingensmith G; Rewers M
    Pediatr Diabetes; 2004 Mar; 5(1):16-9. PubMed ID: 15043685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of novel dual wave meal bolus and its impact on glycated hemoglobin A1c level in children with type 1 diabetes.
    Pańkowska E; Szypowska A; Lipka M; Szpotańska M; Błazik M; Groele L
    Pediatr Diabetes; 2009 Aug; 10(5):298-303. PubMed ID: 19175902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial clinical remission in type 1 diabetes: a comparison of the accuracy of total daily dose of insulin of <0.3 units/kg/day to the gold standard insulin-dose adjusted hemoglobin A1c of ≤9 for the detection of partial clinical remission.
    Lundberg RL; Marino KR; Jasrotia A; Maranda LS; Barton BA; Alonso LC; Nwosu BU
    J Pediatr Endocrinol Metab; 2017 Aug; 30(8):823-830. PubMed ID: 28753540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial remission phase and metabolic control in type 1 diabetes mellitus in children and adolescents.
    Böber E; Dündar B; Büyükgebiz A
    J Pediatr Endocrinol Metab; 2001 Apr; 14(4):435-41. PubMed ID: 11327378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individual and diabetes presentation characteristics associated with partial remission status in children and adults evaluated up to 12 months following diagnosis of type 1 diabetes: An ADDRESS-2 (After Diagnosis Diabetes Research Support System-2) study analysis.
    Humphreys A; Bravis V; Kaur A; Walkey HC; Godsland IF; Misra S; Johnston DG; Oliver NS
    Diabetes Res Clin Pract; 2019 Sep; 155():107789. PubMed ID: 31326456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The remission phase in adolescents and young adults with newly diagnosed type 1 diabetes mellitus: prevalence, predicting factors and glycemic control during follow-up.
    Yazidi M; Mahjoubi S; Oueslati I; Chaker F; Chihaoui M
    Arch Endocrinol Metab; 2022 Apr; 66(2):222-228. PubMed ID: 35315990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes in youth beyond the first year of type 1 diabetes: Results of the Pediatric Diabetes Consortium (PDC) type 1 diabetes new onset (NeOn) study.
    Cengiz E; Cheng P; Ruedy KJ; Kollman C; Tamborlane WV; Klingensmith GJ; Gal RL; Silverstein J; Lee J; Redondo MJ; Beck RW;
    Pediatr Diabetes; 2017 Nov; 18(7):566-573. PubMed ID: 27758023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Young children (<5 yr) and adolescents (>12 yr) with type 1 diabetes mellitus have low rate of partial remission: diabetic ketoacidosis is an important risk factor.
    Bowden SA; Duck MM; Hoffman RP
    Pediatr Diabetes; 2008 Jun; 9(3 Pt 1):197-201. PubMed ID: 18547233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemoglobin A1c Trajectory in Pediatric Patients with Newly Diagnosed Type 1 Diabetes.
    Prahalad P; Yang J; Scheinker D; Desai M; Hood K; Maahs DM
    Diabetes Technol Ther; 2019 Aug; 21(8):456-461. PubMed ID: 31180244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in insulin sensitivity in the partial remission phase of childhood type 1 diabetes; a longitudinal cohort study.
    Mørk FCB; Madsen JOB; Jensen AK; Hall GV; Pilgaard KA; Pociot F; Johannesen J
    Diabet Med; 2022 Feb; 39(2):e14702. PubMed ID: 34564895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric Diabetes Consortium Type 1 Diabetes New Onset (NeOn) Study: factors associated with HbA1c levels one year after diagnosis.
    Redondo MJ; Connor CG; Ruedy KJ; Beck RW; Kollman C; Wood JR; Buckingham B; Klingensmith GJ; Silverstein J; Tamborlane WV;
    Pediatr Diabetes; 2014 Jun; 15(4):294-302. PubMed ID: 23889707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete remission in children and adolescents with type 1 diabetes mellitus-prevalence and factors.
    Podolakova K; Barak L; Jancova E; Tarnokova S; Podracka L; Dobiasova Z; Skopkova M; Gasperikova D; Stanik J
    Sci Rep; 2023 Apr; 13(1):6790. PubMed ID: 37100887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial Clinical Remission of Type 1 Diabetes: The Need for an Integrated Functional Definition Based on Insulin-Dose Adjusted A1c and Insulin Sensitivity Score.
    Nwosu BU
    Front Endocrinol (Lausanne); 2022; 13():884219. PubMed ID: 35592786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum leptin concentrations in children with type 1 diabetes mellitus: relationship to body mass index, insulin dose, and glycemic control.
    Soliman AT; Omar M; Assem HM; Nasr IS; Rizk MM; El Matary W; El Alaily RK
    Metabolism; 2002 Mar; 51(3):292-6. PubMed ID: 11887162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial remission in type 1 diabetes and associated factors: Analysis based on the insulin dose-adjusted hemoglobin A1c in children and adolescents from a regional diabetes center, Auckland, New Zealand.
    Chiavaroli V; Derraik JGB; Jalaludin MY; Albert BB; Ramkumar S; Cutfield WS; Hofman PL; Jefferies CA
    Pediatr Diabetes; 2019 Nov; 20(7):892-900. PubMed ID: 31237756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors contributing to partial remission in type 1 diabetes: analysis based on the insulin dose-adjusted HbA1c in 3657 children and adolescents from Germany and Austria.
    Nagl K; Hermann JM; Plamper M; Schröder C; Dost A; Kordonouri O; Rami-Merhar B; Holl RW
    Pediatr Diabetes; 2017 Sep; 18(6):428-434. PubMed ID: 27416952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of factors determining an HbA1c concentration ≤7.5% in patients with type 1 diabetes.
    Yamada E; Okada S; Nakajima Y; Bastie C; Tagaya Y; Osaki A; Shimoda Y; Shibusawa R; Saito T; Ozawa A; Yamada M
    J Diabetes; 2018 Feb; 10(2):140-147. PubMed ID: 28544548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early Initiation of Diabetes Devices Relates to Improved Glycemic Control in Children with Recent-Onset Type 1 Diabetes Mellitus.
    Patton SR; Noser AE; Youngkin EM; Majidi S; Clements MA
    Diabetes Technol Ther; 2019 Jul; 21(7):379-384. PubMed ID: 31166808
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolic outcomes in young children with type 1 diabetes differ between treatment centers: the Hvidoere Study in Young Children 2009.
    de Beaufort CE; Lange K; Swift PG; Aman J; Cameron F; Castano L; Dorchy H; Fisher LK; Hoey H; Kaprio E; Kocova M; Neu A; Njolstad PR; Phillip M; Schoenle E; Robert JJ; Urukami T; Vanelli M; Danne T; Barrett T; Chiarelli F; Aanstoot HJ; Mortensen HB;
    Pediatr Diabetes; 2013 Sep; 14(6):422-8. PubMed ID: 22957743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.